New options to treat schizophrenia, COPD
A clever combination drug offers new help for schizophrenia with reduced side effects, while Dupixent expands its footprint to COPD.
September 9, 2024
Welcome to the September 2024 Drug Pipeline Insights Report
Something old for COPD and something new for schizophrenia – each offers a unique approach for cases that have failed other treatments. This latest edition showcases:
- A new mechanism for schizophrenia with reduced side effects
- An expanded drug indication for top 10 seller, Dupixent: COPD
Don't want to read the full report? Download the summary.
New innovative treatments for hemophilia B, RSV, COPD
Cutting-edge research in gene therapy, mRNA editing and blood enzymes pays off with powerful new advances for these drug classes.
Optum Rx Drug Pipeline Insights Reports
Read the most recent quarterly reports on new drugs coming down the pipeline.
The new drugs plan sponsors need to watch for
See which trends to consider when assessing the pharmacy benefit, which new drugs may be flying under the radar and what's coming.